Tag: Renal Cell Carcinoma
-

Understanding Immunotherapy Resistance in Kidney Cancer: The Role of Myeloid Cell Signaling
Overview: A New Mechanism Driving Immunotherapy Resistance in Kidney Cancer Immunotherapy has transformed the treatment landscape for advanced renal cell carcinoma (RCC), offering durable responses for some patients. Yet a significant proportion of individuals experience resistance, limiting the long-term effectiveness of immune-based therapies. A landmark study published in Immunity in October 2025 identifies a key…
-

Unraveling Immunotherapy Resistance in Kidney Cancer: The Role of Myeloid Cell Signaling
Overview: Immunotherapy and the Challenge in Advanced Kidney Cancer Immunotherapy has transformed treatment for many cancers, including renal cell carcinoma (RCC). Yet a significant subset of patients with advanced RCC experience limited benefit due to intrinsic or acquired resistance. A recent research focus centers on the tumor microenvironment, where immune and myeloid cells communicate in…
-

Myeloid-Driven Immunotherapy Resistance in Kidney Cancer: Interferon Signaling Under Scrutiny
Overview: A New Mechanism Behind Immunotherapy Resistance in Kidney Cancer Immunotherapy has transformed the treatment landscape for advanced renal cell carcinoma (RCC), but responses remain inconsistent. A landmark study published in Immunity (October 2025) by researchers including Dana-Farber Cancer Institute’s Eliezer M. Van Allen, MD, identifies a critical role for myeloid cells in shaping resistance…
-

PRMT5 Inhibition Induces Ferroptosis in Renal Cell Carcinoma
Understanding Ferroptosis and Its Relevance in Cancer Ferroptosis is a recently discovered form of regulated cell death that is distinct from apoptosis and necrosis. Characterized by the accumulation of lipid peroxides and iron dependence, ferroptosis plays a crucial role in tumor suppression, making it a promising target for cancer therapy. This unique cell death mechanism…
-

PRMT5 Inhibition and Its Role in Inducing Ferroptosis in Renal Cell Carcinoma
Understanding Ferroptosis and Its Therapeutic Potential Ferroptosis is an emerging regulated cell death mechanism that has garnered significant attention for its potential in cancer therapy. This process is characterized by the rupture of the outer cell membrane and mitochondrial collapse, primarily driven by lipid peroxidation and iron accumulation. Recent studies have suggested that ferroptosis plays…
-

PRMT5 Inhibition: A Pathway to Ferroptosis in Renal Cell Carcinoma
Introduction to Ferroptosis and Renal Cell Carcinoma Renal cell carcinoma (RCC), the most prevalent form of kidney cancer in adults, presents significant challenges in treatment options. As research advances, one promising avenue of exploration is ferroptosis, a regulated form of cell death that has recently emerged as a potential therapeutic target in cancer therapy. This…
